Kara joined FARA’s patient engagement team in 2023 and brings nearly a decade of experience in biotech and drug development, specializing in patient advocacy and engagement. In her role at FARA, Kara focuses on developing mutually beneficial opportunities for industry partners to engage with the FA community and support FARA programs through sponsorship and other partnership mechanisms. In addition, she supports patient engagement and education activities and programs. Prior to joining FARA, Kara worked at Reata Pharmaceuticals and quickly built strong professional and personal connections with the FA community along the way. She holds a B.S. from Texas A&M University in Biomedical Sciences with a focus in neuroscience.
Director of Corporate Partnership